BFR92PE6327HTSA1

BFR92P Low Noise Silicon Bipolar RF Transistor • For broadband amplifiers up to 2 GHz and fast non-saturated switches at collector currents from 0.5 mA to 20 mA • Pb-free (RoHS compliant) package • Qualification report according to AEC-Q101 available ESD (Electrostatic discharge) sensitive device, observe handling precaution! Type BFR92P Marking GFs Pin Configuration 1=B 2=E Package SOT23 3=C Maximum Ratings at TA = 25 °C, unless otherwise specified Parameter Symbol Value Unit Collector-emitter voltage VCEO 15 Collector-emitter voltage VCES 20 Collector-base voltage VCBO 20 Emitter-base voltage VEBO 2.5 Collector current IC 45 Base current IB 4 Total power dissipation1) Ptot 280 mW Junction temperature TJ 150 °C Storage temperature TStg V mA TS ≤ 93 °C -55 ... 150 Thermal Resistance Parameter Symbol Junction - soldering point2) RthJS 1T S is 2For Value Unit 205 K/W measured on the collector lead at the soldering point to the pcb the definition of RthJS please refer to Application Note AN077 (Thermal Resistance Calculation) 1 2013-11-21 BFR92P Electrical Characteristics at T A = 25 °C, unless otherwise specified Symbol Parameter Values Unit min. typ. max. 15 - - V ICES - - 10 µA ICBO - - 100 nA IEBO - - 100 µA hFE 70 100 140 - DC Characteristics Collector-emitter breakdown voltage V(BR)CEO IC = 1 mA, I B = 0 Collector-emitter cutoff current VCE = 20 V, VBE = 0 Collector-base cutoff current VCB = 10 V, IE = 0 Emitter-base cutoff current VEB = 2.5 V, IC = 0 DC current gain IC = 15 mA, VCE = 8 V, pulse measured 2 2013-11-21 BFR92P Electrical Characteristics at TA = 25 °C, unless otherwise specified Symbol Values Parameter Unit min. typ. max. 3.5 5 - Ccb - 0.39 0.55 Cce - 0.23 - Ceb - 0.64 - AC Characteristics (verified by random sampling) Transition frequency fT GHz IC = 15 mA, VCE = 8 V, f = 500 MHz Collector-base capacitance pF VCB = 10 V, f = 1 MHz, VBE = 0 , emitter grounded Collector emitter capacitance VCE = 10 V, f = 1 MHz, VBE = 0 , base grounded Emitter-base capacitance VEB = 0.5 V, f = 1 MHz, VCB = 0 , collector grounded Minimum noise figure dB NFmin IC = 2 mA, VCE = 6 V, ZS = ZSopt , f = 900 MHz - 1.4 - - 2 - - 16 - - 10.5 - IC = 2 mA, VCE = 6 V, ZS = ZSopt , f = 1.8 GHz Power gain, maximum available1) Gma IC = 15 mA, VCE = 8 V, ZS = ZSopt, ZL = ZLopt , f = 900 MHz IC = 15 mA, VCE = 8 V, ZS = ZSopt, ZL = ZLopt, f = 1.8 GHz |S21e|2 Transducer gain dB IC = 15 mA, VCE = 8 V, ZS = ZL = 50 Ω, f = 900 MHz - 13 - IC = 15 mA, VCE = 8 V, ZS = ZL = 50 Ω, f = 1.8 MHz - 7.5 - 1/2 ma = |S21e / S12e | (k-(k²-1) ) 1G 3 2013-11-21 BFR92P Total power dissipation P tot = ƒ(TS) 300 mW 250 Ptot 225 200 175 150 125 100 75 50 25 0 0 15 30 45 60 75 90 105 120 °C 150 TS 4 2013-11-21 Package SOT23 5 BFR92P 2013-11-21 BFR92P Edition 2009-11-16 Published by Infineon Technologies AG 81726 Munich, Germany  2009 Infineon Technologies AG All Rights Reserved. Legal Disclaimer The information given in this document shall in no event be regarded as a guarantee of conditions or characteristics. With respect to any examples or hints given herein, any typical values stated herein and/or any information regarding the application of the device, Infineon Technologies hereby disclaims any and all warranties and liabilities of any kind, including without limitation, warranties of non-infringement of intellectual property rights of any third party. Information For further information on technology, delivery terms and conditions and prices, please contact the nearest Infineon Technologies Office (). Warnings Due to technical requirements, components may contain dangerous substances. For information on the types in question, please contact the nearest Infineon Technologies Office. Infineon Technologies components may be used in life-support devices or systems only with the express written approval of Infineon Technologies, if a failure of such components can reasonably be expected to cause the failure of that life-support device or system or to affect the safety or effectiveness of that device or system. Life support devices or systems are intended to be implanted in the human body or to support and/or maintain and sustain and/or protect human life. If they fail, it is reasonable to assume that the health of the user or other persons may be endangered. 6 2013-11-21